These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 25747754

  • 1. Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.
    Bostick B, Habibi J, DeMarco VG, Jia G, Domeier TL, Lambert MD, Aroor AR, Nistala R, Bender SB, Garro M, Hayden MR, Ma L, Manrique C, Sowers JR.
    Am J Physiol Heart Circ Physiol; 2015 May 01; 308(9):H1126-35. PubMed ID: 25747754
    [Abstract] [Full Text] [Related]

  • 2. Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females.
    Jia G, Habibi J, DeMarco VG, Martinez-Lemus LA, Ma L, Whaley-Connell AT, Aroor AR, Domeier TL, Zhu Y, Meininger GA, Mueller KB, Jaffe IZ, Sowers JR.
    Hypertension; 2015 Dec 01; 66(6):1159-1167. PubMed ID: 26441470
    [Abstract] [Full Text] [Related]

  • 3. Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice.
    Aroor AR, Habibi J, Kandikattu HK, Garro-Kacher M, Barron B, Chen D, Hayden MR, Whaley-Connell A, Bender SB, Klein T, Padilla J, Sowers JR, Chandrasekar B, DeMarco VG.
    Cardiovasc Diabetol; 2017 May 05; 16(1):61. PubMed ID: 28476142
    [Abstract] [Full Text] [Related]

  • 4. Enhanced endothelium epithelial sodium channel signaling prompts left ventricular diastolic dysfunction in obese female mice.
    Jia G, Habibi J, Aroor AR, Hill MA, DeMarco VG, Lee LE, Ma L, Barron BJ, Whaley-Connell A, Sowers JR.
    Metabolism; 2018 Jan 05; 78():69-79. PubMed ID: 28920862
    [Abstract] [Full Text] [Related]

  • 5. Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.
    DeMarco VG, Habibi J, Jia G, Aroor AR, Ramirez-Perez FI, Martinez-Lemus LA, Bender SB, Garro M, Hayden MR, Sun Z, Meininger GA, Manrique C, Whaley-Connell A, Sowers JR.
    Hypertension; 2015 Jul 05; 66(1):99-107. PubMed ID: 26015449
    [Abstract] [Full Text] [Related]

  • 6. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.
    Bender SB, DeMarco VG, Padilla J, Jenkins NT, Habibi J, Garro M, Pulakat L, Aroor AR, Jaffe IZ, Sowers JR.
    Hypertension; 2015 May 05; 65(5):1082-8. PubMed ID: 25712719
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
    Ohtake M, Hattori T, Murase T, Takahashi K, Takatsu M, Ohtake M, Miyachi M, Watanabe S, Cheng XW, Murohara T, Nagata K.
    Nagoya J Med Sci; 2014 Feb 05; 76(1-2):59-72. PubMed ID: 25129992
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism.
    Hattori T, Murase T, Iwase E, Takahashi K, Ohtake M, Tsuboi K, Ohtake M, Miyachi M, Murohara T, Nagata K.
    Nagoya J Med Sci; 2013 Feb 05; 75(1-2):81-92. PubMed ID: 23544271
    [Abstract] [Full Text] [Related]

  • 9. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, Takenaka K, Yatomi Y, Fujita T.
    J Hypertens; 2008 Jul 05; 26(7):1453-62. PubMed ID: 18551023
    [Abstract] [Full Text] [Related]

  • 10. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
    Michea L, Villagrán A, Urzúa A, Kuntsmann S, Venegas P, Carrasco L, Gonzalez M, Marusic ET.
    Hypertension; 2008 Aug 05; 52(2):295-300. PubMed ID: 18591458
    [Abstract] [Full Text] [Related]

  • 11. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S, Whaley-Connell A, Habibi J, Appesh L, Hayden MR, Karuparthi PR, Qazi M, Morris EM, Cooper SA, Link CD, Stump C, Hay M, Ferrario C, Sowers JR.
    Endocrinology; 2007 Aug 05; 148(8):3773-80. PubMed ID: 17494996
    [Abstract] [Full Text] [Related]

  • 12. Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats.
    Wang H, da Silva J, Alencar A, Zapata-Sudo G, Lin MR, Sun X, Ahmad S, Ferrario CM, Groban L.
    J Cardiovasc Pharmacol; 2016 Jul 05; 68(1):49-57. PubMed ID: 26981683
    [Abstract] [Full Text] [Related]

  • 13. Endothelial cell-specific mineralocorticoid receptor activation promotes diastolic dysfunction in diet-induced obese male mice.
    Aroor A, DeMarco VG, Whaley-Connell AT, Jia G, Yang Y, Sharma N, Naz H, Hans C, Hayden MR, Hill MA, Sowers JR, Manrique-Acevedo C, Lastra G.
    Am J Physiol Regul Integr Comp Physiol; 2023 Jan 01; 324(1):R90-R101. PubMed ID: 36440901
    [Abstract] [Full Text] [Related]

  • 14. Daily exercise prevents diastolic dysfunction and oxidative stress in a female mouse model of western diet induced obesity by maintaining cardiac heme oxygenase-1 levels.
    Bostick B, Aroor AR, Habibi J, Durante W, Ma L, DeMarco VG, Garro M, Hayden MR, Booth FW, Sowers JR.
    Metabolism; 2017 Jan 01; 66():14-22. PubMed ID: 27923445
    [Abstract] [Full Text] [Related]

  • 15. Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.
    Jia G, Habibi J, Bostick BP, Ma L, DeMarco VG, Aroor AR, Hayden MR, Whaley-Connell AT, Sowers JR.
    Hypertension; 2015 Mar 01; 65(3):531-9. PubMed ID: 25489061
    [Abstract] [Full Text] [Related]

  • 16. Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression.
    Habibi J, DeMarco VG, Ma L, Pulakat L, Rainey WE, Whaley-Connell AT, Sowers JR.
    Am J Physiol Heart Circ Physiol; 2011 Apr 01; 300(4):H1484-91. PubMed ID: 21239636
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y, Zhang F, Zhao S, Li Y, Chen X, Gao E, Xu X, Xiong Z, Zhang X, Zhang J, Zhao H, Wang W, Wang H, Guo Y, Liu Y, Li C, Wang S, Zhang L, Yan W, Tao L.
    Cardiovasc Res; 2018 Aug 01; 114(10):1335-1349. PubMed ID: 29668847
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity.
    Lother A, Bergemann S, Kowalski J, Huck M, Gilsbach R, Bode C, Hein L.
    Cardiovasc Res; 2018 Feb 01; 114(2):282-290. PubMed ID: 28430882
    [Abstract] [Full Text] [Related]

  • 19. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
    Zhang X, Zhang Z, Yang Y, Suo Y, Liu R, Qiu J, Zhao Y, Jiang N, Liu C, Tse G, Li G, Liu T.
    Cardiovasc Diabetol; 2018 Dec 27; 17(1):160. PubMed ID: 30591063
    [Abstract] [Full Text] [Related]

  • 20. An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in Mice.
    Carbone S, Mauro AG, Prestamburgo A, Halquist MS, Narayan P, Potere N, Mezzaroma E, Van Tassell BW, Abbate A, Toldo S.
    J Cardiovasc Pharmacol; 2018 Dec 27; 72(6):303-307. PubMed ID: 30422890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.